List of Tables
Table 1. Global In Vivo Pharmacology Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global In Vivo Pharmacology Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global In Vivo Pharmacology Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global In Vivo Pharmacology Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global In Vivo Pharmacology Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global In Vivo Pharmacology Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global In Vivo Pharmacology Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global In Vivo Pharmacology Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Pharmacology Service as of 2024)
Table 11. Global In Vivo Pharmacology Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global In Vivo Pharmacology Service Companies Headquarters
Table 13. Global In Vivo Pharmacology Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global In Vivo Pharmacology Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global In Vivo Pharmacology Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global In Vivo Pharmacology Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global In Vivo Pharmacology Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. In Vivo Pharmacology Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America In Vivo Pharmacology Service Growth Accelerators and Market Barriers
Table 25. North America In Vivo Pharmacology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe In Vivo Pharmacology Service Growth Accelerators and Market Barriers
Table 27. Europe In Vivo Pharmacology Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific In Vivo Pharmacology Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific In Vivo Pharmacology Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America In Vivo Pharmacology Service Investment Opportunities and Key Challenges
Table 31. Central and South America In Vivo Pharmacology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa In Vivo Pharmacology Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa In Vivo Pharmacology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. NuChem Sciences Inc Corporation Information
Table 35. NuChem Sciences Inc Description and Major Businesses
Table 36. NuChem Sciences Inc Product Features and Attributes
Table 37. NuChem Sciences Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. NuChem Sciences Inc Revenue Proportion by Product in 2024
Table 39. NuChem Sciences Inc Revenue Proportion by Application in 2024
Table 40. NuChem Sciences Inc Revenue Proportion by Geographic Area in 2024
Table 41. NuChem Sciences Inc In Vivo Pharmacology Service SWOT Analysis
Table 42. NuChem Sciences Inc Recent Developments
Table 43. Eurofins Discovery Corporation Information
Table 44. Eurofins Discovery Description and Major Businesses
Table 45. Eurofins Discovery Product Features and Attributes
Table 46. Eurofins Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Eurofins Discovery Revenue Proportion by Product in 2024
Table 48. Eurofins Discovery Revenue Proportion by Application in 2024
Table 49. Eurofins Discovery Revenue Proportion by Geographic Area in 2024
Table 50. Eurofins Discovery In Vivo Pharmacology Service SWOT Analysis
Table 51. Eurofins Discovery Recent Developments
Table 52. Oncodesign Services Corporation Information
Table 53. Oncodesign Services Description and Major Businesses
Table 54. Oncodesign Services Product Features and Attributes
Table 55. Oncodesign Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Oncodesign Services Revenue Proportion by Product in 2024
Table 57. Oncodesign Services Revenue Proportion by Application in 2024
Table 58. Oncodesign Services Revenue Proportion by Geographic Area in 2024
Table 59. Oncodesign Services In Vivo Pharmacology Service SWOT Analysis
Table 60. Oncodesign Services Recent Developments
Table 61. Jubilant Biosys Corporation Information
Table 62. Jubilant Biosys Description and Major Businesses
Table 63. Jubilant Biosys Product Features and Attributes
Table 64. Jubilant Biosys Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Jubilant Biosys Revenue Proportion by Product in 2024
Table 66. Jubilant Biosys Revenue Proportion by Application in 2024
Table 67. Jubilant Biosys Revenue Proportion by Geographic Area in 2024
Table 68. Jubilant Biosys In Vivo Pharmacology Service SWOT Analysis
Table 69. Jubilant Biosys Recent Developments
Table 70. Pharmaron Corporation Information
Table 71. Pharmaron Description and Major Businesses
Table 72. Pharmaron Product Features and Attributes
Table 73. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Pharmaron Revenue Proportion by Product in 2024
Table 75. Pharmaron Revenue Proportion by Application in 2024
Table 76. Pharmaron Revenue Proportion by Geographic Area in 2024
Table 77. Pharmaron In Vivo Pharmacology Service SWOT Analysis
Table 78. Pharmaron Recent Developments
Table 79. Melior Discovery Corporation Information
Table 80. Melior Discovery Description and Major Businesses
Table 81. Melior Discovery Product Features and Attributes
Table 82. Melior Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Melior Discovery Recent Developments
Table 84. NUVISAN GmbH Corporation Information
Table 85. NUVISAN GmbH Description and Major Businesses
Table 86. NUVISAN GmbH Product Features and Attributes
Table 87. NUVISAN GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. NUVISAN GmbH Recent Developments
Table 89. Porsolt Corporation Information
Table 90. Porsolt Description and Major Businesses
Table 91. Porsolt Product Features and Attributes
Table 92. Porsolt Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Porsolt Recent Developments
Table 94. Sygnature Discovery Corporation Information
Table 95. Sygnature Discovery Description and Major Businesses
Table 96. Sygnature Discovery Product Features and Attributes
Table 97. Sygnature Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Sygnature Discovery Recent Developments
Table 99. Aurigene Pharmaceutical Services Ltd Corporation Information
Table 100. Aurigene Pharmaceutical Services Ltd Description and Major Businesses
Table 101. Aurigene Pharmaceutical Services Ltd Product Features and Attributes
Table 102. Aurigene Pharmaceutical Services Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Aurigene Pharmaceutical Services Ltd Recent Developments
Table 104. Reaction Biology Corporation Information
Table 105. Reaction Biology Description and Major Businesses
Table 106. Reaction Biology Product Features and Attributes
Table 107. Reaction Biology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Reaction Biology Recent Developments
Table 109. Addexbio Corporation Information
Table 110. Addexbio Description and Major Businesses
Table 111. Addexbio Product Features and Attributes
Table 112. Addexbio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Addexbio Recent Developments
Table 114. Paraza Pharma, Inc Corporation Information
Table 115. Paraza Pharma, Inc Description and Major Businesses
Table 116. Paraza Pharma, Inc Product Features and Attributes
Table 117. Paraza Pharma, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Paraza Pharma, Inc Recent Developments
Table 119. Aragen Life Sciences Ltd Corporation Information
Table 120. Aragen Life Sciences Ltd Description and Major Businesses
Table 121. Aragen Life Sciences Ltd Product Features and Attributes
Table 122. Aragen Life Sciences Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Aragen Life Sciences Ltd Recent Developments
Table 124. Dalriada Corporation Information
Table 125. Dalriada Description and Major Businesses
Table 126. Dalriada Product Features and Attributes
Table 127. Dalriada Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Dalriada Recent Developments
Table 129. Biocytogen Corporation Information
Table 130. Biocytogen Description and Major Businesses
Table 131. Biocytogen Product Features and Attributes
Table 132. Biocytogen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Biocytogen Recent Developments
Table 134. Charles River Laboratories Corporation Information
Table 135. Charles River Laboratories Description and Major Businesses
Table 136. Charles River Laboratories Product Features and Attributes
Table 137. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Charles River Laboratories Recent Developments
Table 139. Pharmacelsu Corporation Information
Table 140. Pharmacelsu Description and Major Businesses
Table 141. Pharmacelsu Product Features and Attributes
Table 142. Pharmacelsu Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Pharmacelsu Recent Developments
Table 144. HitGen Inc Corporation Information
Table 145. HitGen Inc Description and Major Businesses
Table 146. HitGen Inc Product Features and Attributes
Table 147. HitGen Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. HitGen Inc Recent Developments
Table 149. TCG Lifesciences Corporation Information
Table 150. TCG Lifesciences Description and Major Businesses
Table 151. TCG Lifesciences Product Features and Attributes
Table 152. TCG Lifesciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. TCG Lifesciences Recent Developments
Table 154. Raw Materials Key Suppliers
Table 155. Distributors List
Table 156. Market Trends and Market Evolution
Table 157. Market Drivers and Opportunities
Table 158. Market Challenges, Risks, and Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. In Vivo Pharmacology Service Product Picture
Figure 2. Global In Vivo Pharmacology Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Small Molecule Screening Product Picture
Figure 4. Large Molecule Screening Product Picture
Figure 5. Others Product Picture
Figure 6. Global In Vivo Pharmacology Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Neurological Diseases
Figure 8. Cardiovascular and Metabolic Diseases
Figure 9. Skin Diseases
Figure 10. Others
Figure 11. In Vivo Pharmacology Service Report Years Considered
Figure 12. Global In Vivo Pharmacology Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 14. Global In Vivo Pharmacology Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global In Vivo Pharmacology Service Revenue Market Share by Region (2020-2031)
Figure 16. Global In Vivo Pharmacology Service Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Small Molecule Screening Revenue Market Share by Player in 2024
Figure 19. Large Molecule Screening Revenue Market Share by Player in 2024
Figure 20. Others Revenue Market Share by Player in 2024
Figure 21. Global In Vivo Pharmacology Service Revenue Market Share by Type (2020-2031)
Figure 22. Global In Vivo Pharmacology Service Revenue Market Share by Application (2020-2031)
Figure 23. North America In Vivo Pharmacology Service Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players In Vivo Pharmacology Service Revenue (US$ Million) in 2024
Figure 25. North America In Vivo Pharmacology Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America In Vivo Pharmacology Service Revenue (US$ Million) by Application (2020-2031)
Figure 27. US In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 28. Canada In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 30. Europe In Vivo Pharmacology Service Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players In Vivo Pharmacology Service Revenue (US$ Million) in 2024
Figure 32. Europe In Vivo Pharmacology Service Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe In Vivo Pharmacology Service Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 35. France In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 37. Italy In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 38. Russia In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific In Vivo Pharmacology Service Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players In Vivo Pharmacology Service Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific In Vivo Pharmacology Service Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific In Vivo Pharmacology Service Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 44. Japan In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 46. Australia In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 47. India In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore In Vivo Pharmacology Service Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America In Vivo Pharmacology Service Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players In Vivo Pharmacology Service Revenue (US$ Million) in 2024
Figure 55. Central and South America In Vivo Pharmacology Service Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America In Vivo Pharmacology Service Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil In Vivo Pharmacology Service Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina In Vivo Pharmacology Service Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa In Vivo Pharmacology Service Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players In Vivo Pharmacology Service Revenue (US$ Million) in 2024
Figure 61. South America In Vivo Pharmacology Service Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa In Vivo Pharmacology Service Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries In Vivo Pharmacology Service Revenue (2020-2025) & (US$ Million)
Figure 64. Israel In Vivo Pharmacology Service Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt In Vivo Pharmacology Service Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa In Vivo Pharmacology Service Revenue (2020-2025) & (US$ Million)
Figure 67. In Vivo Pharmacology Service Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
